Underpenetrated U.S. Gastric Banding Market Has Room For Two
This article was originally published in The Gray Sheet
Executive Summary
With Johnson & Johnson expected to launch its Realize adjustable gastric band in the United States by the end of the year, what physicians and analysts consider a highly underpenetrated market will finally have some competition
You may also be interested in...
Obesity 2015: Less Invasive Options Will Drive Growth In Market Hungry For Solutions
Nearly half of the world’s adult population will be overweight or obese by 2030 and obesity is tied to more than 40 diseases. Enterprising companies are heeding the call with increasingly less invasive weight loss devices, while an amenable regulatory environment means the marketplace will welcome some of these innovations in 2015.
FDA Weighs Patients' Risk Tolerance in Approving Obesity Device
The agency approved EnteroMedics’ Maestro neuromodulator to treat obesity despite the device not meeting endpoints in its pivotal trial. The agency relied in part on a survey that found obese patients willing to take more risks in exchange for weight loss.
FDA Weighs Patients' Risk Tolerance in Approving Obesity Device
The agency approved EnteroMedics’ Maestro neuromodulator to treat obesity despite the device not meeting endpoints in its pivotal trial. The agency relied in part on a survey that found obese patients willing to take more risks in exchange for weight loss.